Development, validation, and initial results of the Angioedema Activity Score.

Development, validation, and initial results of the Angioedema Activity Score.

Item
http://www.wikidata.org/entity/Q39371919
Profile of omalizumab in the treatment of chronic spontaneous urticariaInsights and advances in chronic urticaria: a Canadian perspective.Efficacy of Treatment of Non-hereditary Angioedema.[Useful tools for documenting urticaria].[Diagnosis and therapy of chronic urticaria-what is expected from the revision and update of the international guidelines? A report of the public consensus conference "URTICARIA 2012"].Disease Severity, Activity, Impact, and Control and How to Assess Them in Patients with Hereditary Angioedema.Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data.Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria.Chronic urticaria in most patients is poorly controlled. Results of the development, validation, and real life application of the arabic urticaria control test.Angioedema in Chronic Spontaneous Urticaria Is Underdiagnosed and Has a Substantial Impact: Analyses From ASSURE-CSU.Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update.Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.Revisions to the international guidelines on the diagnosis and therapy of chronic urticaria
P2860

Development, validation, and initial results of the Angioedema Activity Score.

Item
http://www.wikidata.org/entity/Q39371919
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Development, validation, and initial results of the Angioedema Activity Score.
@en
Development, validation, and initial results of the Angioedema Activity Score.
@nl
type
label
Development, validation, and initial results of the Angioedema Activity Score.
@en
Development, validation, and initial results of the Angioedema Activity Score.
@nl
prefLabel
Development, validation, and initial results of the Angioedema Activity Score.
@en
Development, validation, and initial results of the Angioedema Activity Score.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Development, validation, and initial results of the Angioedema Activity Score.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698